Rapid Decline in HCV Incidence among People Who Inject Drugs Associated with National Scale-Up in Coverage of a Combination of Harm Reduction Interventions

Decline in incidence of HIV and hepatitis C virus infection among injecting drug users in Amsterdam; evidence for harm reduction?

(2013) Anneke S. de Vos et al.   ADDICTION

Reduction in HCV Incidence Among Injection Drug Users Attending Needle and Syringe Programs in Australia: A Linkage Study

(2013) Jenny Iversen et al.   AMERICAN JOURNAL OF PUBLIC HEALTH

Combination Interventions to Prevent HCV Transmission Among People Who Inject Drugs: Modeling the Impact of Antiviral Treatment, Needle and Syringe Programs, and Opiate Substitution Therapy

(2013) Natasha K. Martin et al.   CLINICAL INFECTIOUS DISEASES

Risk of transmission associated with sharing drug injecting paraphernalia: analysis of recent hepatitis C virus (HCV) infection using cross-sectional survey data

(2013) N. Palmateer et al.   JOURNAL OF VIRAL HEPATITIS

Commentary on Vickermanet al. (2012): Reducing hepatitis C virus among injection drug users through harm reduction programs

(2012) Crystal M. Smith-Spangler et al.   ADDICTION

Can needle and syringe programmes and opiate substitution therapy achieve substantial reductions in hepatitis C virus prevalence? Model projections for different epidemic settings

(2012) Peter Vickerman et al.   ADDICTION

Uptake of paraphernalia from injecting equipment provision services and its association with sharing of paraphernalia among injecting drug users in Scotland

(2012) E. Aspinall et al.   DRUG AND ALCOHOL DEPENDENCE

Detection of hepatitis C virus RNA in dried blood spots

(2012) Susan Bennett et al.   JOURNAL OF CLINICAL VIROLOGY

The impact of needle and syringe provision and opiate substitution therapy on the incidence of hepatitis C virus in injecting drug users: pooling of UK evidence

(2011) Katy M. E. Turner et al.   ADDICTION

Meta-analysis of hepatitis C seroconversion in relation to shared syringes and drug preparation equipment

(2011) Enrique R. Pouget et al.   ADDICTION

The provision of non-needle/syringe drug injecting paraphernalia in the primary prevention of HCV among IDU: a systematic review

(2011) Michelle Gillies et al.   BMC PUBLIC HEALTH

Evidence for the effectiveness of sterile injecting equipment provision in preventing hepatitis C and human immunodeficiency virus transmission among injecting drug users: a review of reviews

(2010) Norah Palmateer et al.   ADDICTION

Can antiviral therapy for hepatitis C reduce the prevalence of HCV among injecting drug user populations? A modeling analysis of its prevention utility

(2010) Natasha K. Martin et al.   JOURNAL OF HEPATOLOGY

Measuring the incidence, prevalence and genetic relatedness of hepatitis C infections among a community recruited sample of injecting drug users, using dried blood spots

(2010) V. D. Hope et al.   JOURNAL OF VIRAL HEPATITIS

Incidence of hepatitis C in drug injectors: the role of homelessness, opiate substitution treatment, equipment sharing, and community size

(2009) N. CRAINE et al.   EPIDEMIOLOGY AND INFECTION